Mark Woodward's Publications

About Mark Woodward's Publications

Senior Professorial Fellow, Professorial Unit
  • Chair of Statistics, Epidemiology and Women’s Health at Imperial College London
  • Professor of Medical Statistics, Faculty of Medicine, UNSW Sydney
  • PhD ,
  • FMedSci,
  • FAHMS,
  • FESC

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • Statistical analysis plan for the STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER) study: a randomised, open label, controlled trial in subjects with persistent neurological symptoms after COVID-19 infection

    Unknown Date published:

  • Development and calibration of the 2023 Australian cardiovascular disease risk prediction equations: a model updating study

    Medical Journal of Australia Date published:

  • Reproductive factors and the risk of incident peripheral arterial disease hospitalization or death: a cohort study of UK Biobank participants

    American Journal of Obstetrics and Gynecology Date published:

  • Distribution of cardiovascular disease risk based on the updated 2023 guideline-recommended Australian cardiovascular disease risk algorithm and comparison with the 2012 algorithm

    Unknown Date published:

  • Obesity drives the link between liver fat and depression: Cross-sectional and prospective investigations

    Diabetes, Obesity and Metabolism Date published:

  • 418-P: Impact of Intensive Lifestyle Intervention on Kidney Disease Progression in People with Type 2 Diabetes-The Look AHEAD Study

    Diabetes Date published:

  • Sex Hormones Mediate Intensive Lifestyle Intervention-Induced Bone Mineral Density Changes: Look AHEAD Sex Hormone Study

    The Journal of Clinical Endocrinology & Metabolism Date published:

  • Effectiveness of data-driven quality improvement on hospitalizations and health outcomes for people with coronary heart disease in primary care (QUEL): a cluster randomised controlled trial with 24-month follow-up

    Unknown Date published:

  • Health and economic benefits of improving pre-hospital identification of stroke in Australian women: a modelling study

    Medical Journal of Australia Date published:

  • The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort

    The Journal of Clinical Endocrinology & Metabolism Date published:

  • Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study

    Journal of Clinical Epidemiology Date published:

  • Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR

    Kidney International Reports Date published:

  • Socioeconomic Status, Clinical Characteristics and Mortality in Two Subtypes of ALD According to the New SLD Classifications

    Liver International Communications Date published:

  • Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study

    The Journal of Clinical Endocrinology & Metabolism Date published:

  • Frailty and prescriptions of secondary prevention medications in older people with diabetes and coronary heart disease-An observational study in Vietnam

    Australasian Journal on Ageing Date published: